NEW YORK (Reuters Health) – Androgen suppression therapy – and its attendant side effects — may not be necessary for patients with intermediate-risk prostate cancer treated with combination…
NEW YORK (Reuters Health) – The cholesterol-lowering drug pravastatin prevents coronary heart disease in blacks, according to trial results published in the December American Heart Journal. “It’s very…
NEW YORK (Reuters Health) – In patients with atrial fibrillation, a body mass index (BMI) of 27.0 kg/meters-squared or higher increases the risk for left atrial/left atrial appendage…
NEW YORK (Reuters Health) – Endoscopic resection of large colonic polyps is a safe and cost-effective alternative to surgery, according to a paper in the December issue of…
NEW YORK (Reuters Health) – When allergic asthma in children can’t be controlled with medium- to high-dose corticosteroids, add-on omalizumab is effective and well tolerated, new research shows.…
NEW YORK (Reuters Health) – Outpatient infusions of ketamine can significantly improve the severe pain of complex regional pain syndrome, a chronic problem after trauma, a small study…
NEW YORK (Reuters Health) – Nearly all patients have complications from chemoradiation for head and neck cancer, a study in the Archives of Otolaryngology: Head and Neck Surgery…
NEW YORK (Reuters Health) – Interactions between clopidogrel and proton pump inhibitors (PPI) appear to have only a small effect, if any, in older patients, report researchers from…
NEW YORK (Reuters Health) – In patients with systemic lupus erythematosus (SLE), the antimalarial drugs chloroquine and hydroxychloroquine have wide-ranging benefits and a good safety profile, published studies…
NEW YORK (Reuters Health) – Many common medications – including some antidepressants and antihypertensives – can interfere with a test that distinguishes Cushing’s syndrome from pseudo-Cushing’s syndrome, investigators…
NEW YORK (Reuters Health) – Extremely few stroke patients have unsuspected coagulopathies that would prevent thrombolysis — a finding that supports the practice of starting the treatment without…
NEW YORK (Reuters Health) – A lower than normal hematocrit level before percutaneous coronary intervention (PCI) and a drop in hematocrit after PCI are “strongly associated” with long-term…
